How Licensing Expands Access to Innovative Lens Designs

October 2025 - Strategy / Licensing

Scale innovation globally by transforming proven lens designs into accessible, reproducible solutions through structured licensing. Explore our licensing platform →

In the specialty contact lens industry, innovation often begins in a single clinic or laboratory, driven by clinical insight and years of hands-on experience. However, the true value of a design is realized when it can be reliably reproduced and made accessible to practitioners and patients globally. This is where licensing plays a critical role. It transforms individual innovation into scalable clinical solutions, bridging the gap between design and widespread adoption.

Why Licensing Matters

Licensing in specialty contact lenses is often associated with validation protocols and technical reproducibility. At its core, licensing creates alignment between innovation and execution, allowing each party to focus on its strengths while contributing to a shared outcome.

From the perspective of a Design Owner, licensing offers:

1. NEW REVENUE STREAMS

   Generate income without the heavy investment of building manufacturing capacity

2. DRIVE ON RESEARCH AND INNOVATION

   Dedicate more time to continuous design refinement

3. BROADER PATIENT IMPACT

   Ensure designs reach more patients beyond local limitations

For the Licensee (Manufacturing Lab), the advantages are equally compelling:

1. IMMEDIATE ACCESS TO PROVEN DESIGNS

   Work with clinically validated lenses already supported by real-world data

2. REDUCED R&D RISK

   Leverage designs where concept development and prototyping are already completed

3. STRONGER AND DIFFERENTIATED PORTFOLIO

   Enhance your offering with unique solutions that stand out in your market

The Importance of Structure

Behind every successful licensing relationship is a solid foundation. A well-defined licensing agreement establishes clarity from the outset, outlining scope of use, duration, quality expectations, and intellectual property protection. This structure is essential to prevent misunderstandings and to ensure that all parties operate with transparency and confidence throughout the collaboration. Validation protocols are equally critical. Each laboratory works with its own equipment, processes, and production workflows, which can introduce variability if not properly managed. A robust validation process ensures that, despite these differences, the lens performs consistently and in line with the original design intent. While these elements may appear procedural, they play a central role in safeguarding quality, protecting intellectual property, and ultimately ensuring patient safety.

Collaboration Beyond Validation

Effective licensing extends well beyond the transfer of a design. It involves sharing the clinical rationale behind the design, supporting laboratories during implementation, and fostering continuous communication between all parties involved. This collaborative approach strengthens both technical and clinical outcomes. As laboratories apply designs within their own markets, they generate valuable insights that can inform future refinements. In turn, this creates a feedback loop that supports ongoing improvement and innovation. When properly structured, licensing evolves into an active partnership rather than a transactional exchange, reinforcing long-term relationships across the ecosystem.

Broader Advantages for the Industry

When licensing is implemented effectively, its impact extends beyond individual organizations and contributes to the evolution of the industry as a whole. Designs can achieve global reach without requiring redundant development efforts, making advanced solutions accessible across multiple regions. At the same time, time to market is significantly reduced, allowing laboratories to respond more quickly to clinical needs.

1. GLOBAL REACH

   Expand designs beyond local regulatory and distribution limitations

2. SPEED TO MARKET

   Launch innovative lenses faster without lengthy internal R&D cycles

3. CONTINUOUS INNOVATION

   Enable independent designers to keep researching and creating

The Role of FocalPoints^® Licensing Platform

A structured and secure environment is essential to support licensing at scale. The FocalPoints Licensing Platform provides a controlled framework for design distribution, integrating validation tools that ensure reproducibility across different production environments. It also enables secure management of intellectual property and licensing agreements, supporting transparency and consistency throughout the process.

By standardizing key workflows, the platform allows Design Owners and Manufacturing Laboratories to collaborate more efficiently while maintaining full control over their respective roles and responsibilities. FocalPoints operates as an enabling infrastructure, supporting structured collaboration between independent parties and facilitating the reliable transfer of complex lens designs across diverse manufacturing settings.

Enabling Scalable Innovation

Licensing is not only a legal or technical framework; it is a strategic approach to scaling innovation, strengthening collaboration, and expanding access to advanced contact lens solutions. By enabling designs to be manufactured globally under controlled and validated conditions, licensing accelerates adoption and supports improved clinical outcomes. In this context, structured platforms play a critical role in connecting stakeholders, and transforming innovation into real-world impact for practitioners and patients alike.

The power of connections, shared knowledge, and business advantages is what makes licensing so impactful. It turns individual innovation into a collective benefit for the entire industry.

Filippo Selden, CEO Advance Medical